CA-MARY-KAY-INC.
What started out as a way for the style community to come together when the pandemic stopped the industry in its tracks has grown into one of the largest gatherings of the fashion industry worldwide. Now, with life opening back up in the US and abroad, Glamhive ’s Digital Spring Style and Beauty Summit on May 22nd will be the final 100% digital summit. Glamhive will launch all future events as a hybrid physical-digital experience.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210520005908/en/
The Spring Summit will be the company’s fifth global digital experience and will once again bring together industry professionals and beauty and style enthusiasts to discuss spring style, skincare in the colder months, getting started in the fashion business and much more.
The all-day, ticketed event will feature 19 panels with 66-plus speakers. Below is an overview of the topics that will be covered by the all-star speaker line-up.
TOPICS:
- Who Made This? How Sustainably Sourced Products Empower Women With Every Purchase
- Style 411: Inside the World of Styling
- Contemporary Costume Design: The Role, The Challenges, And It’s Influence On Fashion
- The Red Carpet Report
- “A Star Is Born” Exclusive Interview with Astrologist Susan Miller
- Exclusive Interview with Bridgerton’s Costume Designer Ellen Mirojnick
- How To Make A Great First Impression Every Time
- Brand Building for Creatives & Entrepreneurs
During the Who Made This? How Sustainably Sourced Products Empower Women With Every Purchase panel, Chief Marketing Officer for Mary Kay Inc., Sheryl Adkins-Green, will host a discussion on the origin of the items inside each of our closets—and how we can better know the innovators behind the fashion styles. Panelists include Jane Mosbacher, Founder and CEO of TO THE MARKET; Matilda Payne Boakye-Ansah, Designer, Eco-Warrior, Social Entrepreneur, Founder of MH Couture and Co-Founder of Xtreme Upcycle; Christelle C. Paul, Founder and Director of Atelier Calla; and Tara Swennen, celebrity stylist.
“We have an opportunity every day to make choices that help protect our environment,” said Sheryl Adkins-Green, “and it’s important to know about the people and products that are making a difference.”
CO-HOSTS
Stephanie Sprangers - Founder & CEO, Glamhive
Johnny Wujek - Celebrity Stylist & Costume Designer to Katy Perry and Mariah Carey
Nicole Chavez - Celebrity Stylist to Kristen Bell and Jessica Simpson
Andrew Fitzsimons - Celebrity hairstylist to The Kardashians
Claire Sulmers - Founder + CEO of Fashion Bomb Daily
SPEAKERS:
Our speakers are celebrity stylists, makeup artists, and image-makers who work with the biggest names in Hollywood and beyond, including Kristen Stewart, Angelina Jolie, Matthew McConaughey, Emily Blunt, Gabrielle Union, Zendaya, Sophie Turner, Amanda Seyfried, Margot Robbie, Lupita Nyong’o, Emma Watson, Rosie Huntington-Whiteley, Claire Danes, Carmen Electra.
CELEBRITY STYLISTS:
Jen Rade, Tara Swennen, Jessica Paster, Nicole Chavez, Sonia Young, Dana Asher Levine, Mimi Lombardo, Joiee Thorpe, Franzy Staedter.
CELEBRITY MAKEUP ARTISTS + HAIRSTYLISTS:
Sheridan Ward, Matey Denno, Matin Maulawizada, Christian Wood, Halley Brisker, Larry Sims
MODERATORS:
Brian Underwood (Oprah Magazine), Brooke Jaffe, (Penske Media), Alexis Bennett (Vogue), Sarah Ball (PEOPLE Magazine), Flavia Nunez (Real Simple), Alana Peden (StyleCaster) and Sheryl Adkins-Green (Mary Kay Inc.)
Tickets to the conference are $149 for an all-day ticket. Presenting sponsor for the Glamhive Digital Spring Style and Beauty Summit is Mary Kay Inc. and its Mary Kay Global Design Studio.
For more information, visit https://www.glamhive.com/live
About Glamhive: Glamhive was founded by entrepreneur Stephanie Sprangers in 2017 with the vision to democratize personal styling and the premise that the confidence that comes with glamour should not be exclusive to the rich and famous.
The online styling experience offers anyone with a WiFi connection access to stylists who will provide them with the support they need to be the best version of themselves. For stylists, it is a seamless end-to-end platform to help them grow their network and their business, 100% virtually.
About Mary Kay
One of the original glass ceiling breakers, Mary Kay Ash founded her beauty company nearly 60 years ago with three goals: develop rewarding opportunities for women, offer irresistible products, and make the world a better place. That dream has blossomed into a multibillion-dollar company with millions of independent sales force members in nearly 40 countries. Mary Kay is dedicated to investing in the science behind beauty and manufacturing cutting-edge skin care, color cosmetics, nutritional supplements and fragrances. Mary Kay is committed to empowering women and their families by partnering with organizations from around the world, focusing on supporting cancer research, protecting survivors from domestic abuse, beautifying our communities, and encouraging children to follow their dreams. Mary Kay Ash’s original vision continues to shine—one lipstick at a time.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210520005908/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
CorriXR Therapeutics, InhaTarget Therapeutics, and Merxin Ltd Announce Strategic Collaboration for the Development of Inhaled Lung Cancer Treatment2.12.2025 14:30:00 CET | Press release
CorriXR Therapeutics, an oncology-focused biotherapeutics company pioneering a ground-breaking gene editing platform technology, InhaTarget Therapeutics, a company dedicated to the early development and clinical validation of innovative treatments of pulmonary diseases by inhalation, and Merxin Ltd, a designer and supplier of inhaler devices, have entered a strategic collaboration to develop a pioneering inhaled genetic therapy targeting lung cancer. The partnership draws upon CorriXR’s proprietary CRISPR-based gene editing platform targeting NRF2, InhaTarget’s proprietary formulation platform and strong experience in pulmonary drug development, and Merxin Ltd’s advanced inhalation device technology. Through their combined expertise, they aim to create a patient-friendly inhaled therapy that delivers targeted treatment directly to lung tumors, maximizing efficacy, minimizing systemic side effects, and offering new hope for patients facing one of the world’s deadliest cancers. Innovativ
Aurigene Oncology Limited Announces Encouraging Initial Data From 1st Two Cohorts of Phase 1 Study of AUR112, an Oral Small Molecule Inhibitor of MALT1, in Relapsed/Refractory Lymphoid Malignancies2.12.2025 14:00:00 CET | Press release
Aurigene Oncology Limited, a clinical-stage biopharmaceutical company developing novel therapies in oncology,today announced initial clinical results from 1st two cohorts of its ongoing Phase 1 clinical trial evaluating AUR112 in patients with relapsed or refractory lymphoid malignancies. Early findings show that AUR112 is safe, well tolerated, demonstrating meaningful clinical activity, with objective responses observed across multiple lymphoma subtypes, including Mantle Cell Lymphoma (MCL) and Marginal Zone Lymphoma (MZL). “We are very encouraged by the early results of the first two cohorts from our Phase 1 study of AUR112,” said Dr. Murali Ramachandra, CEO. “AUR112 has shown a promising initial clinical profile, achieving an overall response rate of 63.6% in the efficacy-evaluable population and 58.3% in the intent-to-treat group. These strong early data, combined with its distinct preclinical and safety characteristics, reinforce our belief that AUR112 has the potential to become
AdvanCell Initiates Phase 2 Expansion Trial of ADVC001, a Novel Targeted Alpha Therapy for Prostate Cancer2.12.2025 14:00:00 CET | Press release
Clinical development of 212Pb-ADVC001 (ADVC001) is advancing rapidly with encouraging Phase 1b data presented at ESMO 2025 The Phase 2 expansion will evaluate 160 MBq and 200 MBq doses of ADVC001 using a randomized, multi-dose-response design and adaptive dosing strategies to optimize clinical outcomes across three indications: metastatic hormone-sensitive prostate cancer (mHSPC) and metastatic castration-resistant prostate cancer (mCRPC) in pre-chemotherapy and post-177Lu-PSMA radioligand therapy (RLT) settings AdvanCell, a clinical-stage radiopharmaceutical company developing innovative targeted alpha therapies for cancer, today announced the initiation of the TheraPb Phase 2 expansion trial (NCT05720130) evaluating its lead investigational candidate, ADVC001, in metastatic prostate cancer. The news follows the encouraging Phase 1b dose escalation results presented at the European Society for Medical Oncology (ESMO) 2025 congress that showed a favorable safety profile and compelling
Luma AI Opens for International Business With Former WPP Executive Jason Day Leading New London Office2.12.2025 14:00:00 CET | Press release
Establishment of the London office follows Luma AI’s $900 million Series C investment led by HUMAIN - marking the company’s first major step towards international scale with plans to deepen partnerships across the UK, European Union, and Saudi Arabia in the first phase of expansion.Former Monks and WPP executive Jason Day was appointed Head of EMEA to launch Luma AI internationally and drive worldwide growth across creative, advertising, gaming, and entertainment sectors.Luma AI plans to add 200 new jobs in London in 2026. Luma AI, the frontier artificial intelligence company building multimodal AGI intelligence and known for its flagship product Dream Machine, today announced a major step in its global expansion with the opening of its first international office in London, UK. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251202217704/en/ LUMA AI OPENS FOR INTERNATIONAL BUSINESS WITH FORMER WPP EXECUTIVE JASON DAY LEADING
Eventbrite Enters into Definitive Agreement to Be Acquired by Bending Spoons for Roughly $500 Million to Accelerate Eventbrite’s Next Phase of Growth2.12.2025 13:30:00 CET | Press release
Eventbrite stockholders to receive $4.50 per share in cash Eventbrite, Inc. (NYSE: EB), the leading global marketplace for shared experiences, announced today that it has entered into a definitive agreement to be acquired by Bending Spoons, in an all-cash transaction valued at approximately $500 million. The acquisition is subject to customary closing conditions and approvals, including regulatory approvals and approval by Eventbrite’s stockholders. “For two decades, Eventbrite has stood at the forefront of the experience economy, helping tens of millions to create, discover, and attend unforgettable events,” said Luca Ferrari, Bending Spoons CEO and Co-Founder. “Joining forces with Bending Spoons will accelerate innovation and strengthen Eventbrite’s tools and resources to bring even more people together through shared live experiences for many years to come. As longstanding fans, we’ve identified a few opportunities that we’re excited about exploring with the Eventbrite team after cl
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom